384 related articles for article (PubMed ID: 1715961)
1. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity.
Koistinen P; Wang C; Curtis JE; McCulloch EA
Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308
[TBL] [Abstract][Full Text] [Related]
3. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
4. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
5. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
Yang GS; Minden MD; McCulloch EA
Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
[TBL] [Abstract][Full Text] [Related]
6. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
Hu ZB; Minden MD; McCulloch EA
Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855
[TBL] [Abstract][Full Text] [Related]
7. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
[TBL] [Abstract][Full Text] [Related]
8. Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia.
Wang C; Koistinen P; Yang GS; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Jun; 5(6):493-9. PubMed ID: 1711640
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
te Boekhorst PA; Löwenberg B; Sonneveld P
Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA
Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841
[TBL] [Abstract][Full Text] [Related]
11. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.
Yang GS; Minden MD; McCulloch EA
Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996
[TBL] [Abstract][Full Text] [Related]
12. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
Tafuri A; Lemoli RM; Chen R; Gulati SC; Clarkson BD; Andreeff M
Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244
[TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
[TBL] [Abstract][Full Text] [Related]
14. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity.
Yang GS; Wang C; Minden MD; McCulloch EA
Leukemia; 1994 Dec; 8(12):2052-9. PubMed ID: 7807994
[TBL] [Abstract][Full Text] [Related]
16. Mast cell growth factor (c-kit ligand) enhances cytokine stimulation of proliferation of the human factor-dependent cell line, M07e.
Hendrie PC; Miyazawa K; Yang YC; Langefeld CD; Broxmeyer HE
Exp Hematol; 1991 Nov; 19(10):1031-7. PubMed ID: 1717302
[TBL] [Abstract][Full Text] [Related]
17. Effects of rGM-CSF and rG-CSF on the cisplatin sensitivity of the blast cells of acute myeloblastic leukemia.
Wang YF; Kelleher CA; Minkin S; McCulloch EA
Leukemia; 1991 Mar; 5(3):239-48. PubMed ID: 1707468
[TBL] [Abstract][Full Text] [Related]
18. Effect of mast cell growth factor on clonogenic blast cell growth in acute myelogenous leukemia.
Siitonen T; Lundström M; Zheng A; Savolainen ER; Koistinen P
Ann Hematol; 1996 Aug; 73(2):71-8. PubMed ID: 8774615
[TBL] [Abstract][Full Text] [Related]
19. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment].
Gotoh A; Kawanishi Y; Kurosawa K; Miyazawa K; Ohtaka M; Aizawa S; Kimura Y; Yoshikawa O; Toyama K
Rinsho Ketsueki; 1993 Jul; 34(7):821-8. PubMed ID: 7689660
[TBL] [Abstract][Full Text] [Related]
20. Response of the blast stem cells of acute myeloblastic leukemia to G-CSF, GM-CSF, or the ligand for C-KIT, alone or in combination.
McCulloch EA; Minkin S; Curtis JE; Minden MD
Hematopathol Mol Hematol; 1996; 10(3):111-22. PubMed ID: 8878730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]